Copyright 2002 eMediaMillWorks, Inc.
(f/k/a Federal
Document Clearing House, Inc.)
Federal Document Clearing House
Congressional Testimony
March 5, 2002 Tuesday
SECTION: CAPITOL HILL HEARING TESTIMONY
LENGTH: 876 words
COMMITTEE:
SENATE HEALTH, EDUCATION, LABOR AND PENSIONS
HEADLINE: HUMAN CLONING
TESTIMONY-BY: EDWARD M. KENNEDY, SENATOR
BODY: STATEMENT OF SENATOR EDWARD M. KENNEDY
HEARING ON CLONING
MARCH 5, 2002
Today we will explore
the extraordinary new field of regenerative medicine.
With this
promising therapy, the cure for diseases that have afflicted millions of
Americans for generations is now within our grasp in our lifetimes - diseases
that deprive people of their dignity, their careers, their ability to recognize
even their own children, and even their very lives. I believe that we owe it to
our fellow citizens to do everything we can to encourage this extraordinary
medical progress that brings such great hope to so many.
We will also
hear today about the dangers of cloning a human being. We will learn that there
are deep-seated moral and ethical objections to ever cloning a human child. I
share these profound objections to cloning. Senator Feinstein and I have
introduced a bill to make such cloning illegal. Senator Harkin and Senator
Specter and Senator Campbell have introduced similar legislation, and many
members of our committee have co-sponsored these bills. But we must not confuse
human cloning with regenerative medicine. One creates a person,
and should be banned. The other provides a cure, and deserves our strong
support. Regenerative medicine involves transferring the genetic material from
one human cell into another human cell in a laboratory dish. It does not involve
reproducing a child or creating carbon copies of ourselves. In our opposition to
human cloning, we must not make the grave mistake of denying to
patients the hope that regenerative medicine brings. Enacting sweeping bans on
regenerative medicine would delay the cures that are so urgently needed by
patients in every community in America.
Many of us listened with close
attention to the hearing on stem cells held in this committee last September. We
heard that stem cells can serve as powerful healers for the human body. These
extraordinary cells can generate new heart muscle for those who have suffered
cardiac damage, new pancreas cells for diabetics and new brain cells for those
with Parkinson's Disease.
But a shadow looms over this research. A
patient's body may reject the very cells intended to provide a cure. To unlock
the potential of stem cell research, doctors are trying to reprogram stem cells
with a patient's own genetic material. Using the breakthrough technique of
nuclear transfer, each one of us could receive transplants or new cells
perfectly matched to our own bodies. That is why this research is so important.
New science always brings new challenges and new debates. But we have
proven in recent years that we can balance the promise of science with the
ethical demands of our society.
Some have said that this research will
put women at risk by subjecting them to undue pressures to donate eggs. Our
legislation addresses this concern by applying to all nuclear transfer research
the same strict ethical standards used in research funded by the federal
government. Many organizations representing women around the nation strongly
reject any prohibitions on this important research. I received a letter
yesterday from the National Partnership for Women and Families, the American
Association of University Women, the American College of Obstetricians and
Gynecologists and the Society for Women's Health Research. Far from wanting
curbs on this research, they regard it as essential to ensuring the health of
women. They write that nuclear transfer research "offers hope to women
struggling to care for parents with Alzheimer's disease or suffering after a
stroke, children with juvenile diabetes, and husbands with heart disease...In
our pursuit of better information, treatment, and cures for women and their
families, we must ensure that the newest and most promising techniques are
available."
In this committee, 25 years ago, we held hearings on whether
to ban the basic techniques of biotechnology.
Time after time, we heard
of the medical advances that this new field of research would bring. Then - as
now - some dismissed this promise as a pipe dream, and urged Congress to forbid
this new field of biotechnology because it seemed new or strange.
Congress rightly rejected those arguments and today patients across
America enjoy breakthrough new biotechnology products that help dissolve clots
in the arteries of stroke victims, fight leukemia, and help those with crippling
arthritis lead active lives.
All of this would have been lost if
Congress had banned the basic research in the 1970's.
During our
previous debate on cloning in 1998, the Senate rejected legislation that would
have enacted sweeping bans on vital medical research.
Congress was right
to defeat unwarranted restrictions on life- saving research in the past, and we
should reject a ban on regenerative medicine now. We should make sure that the
research is done ethically, with appropriate oversight, so that women who donate
eggs are informed of the risks and nature of the research in which they are
participating. Science should always move forward hand in hand with ethics. But
to deny patients the new medical miracles that come from research in
regenerative medicine would be to deny lifesaving cures for future generations.
LOAD-DATE: March 7, 2002